UFP Technologies: Business Model, SWOT Analysis, and Competitors 2026

UFP Technologies, Inc. stands as a leading company in Healthcare. Generating $602.80 million in annual revenue (growing 3.4% year-over-year) and carrying a market capitalization of $1.56 billion, the company has cemented its position as a foundational player in the global Medical Devices landscape. Under the leadership of its leadership team, UFP Technologies, Inc. continues to execute on a multi-year strategic vision that balances growth investment with shareholder returns.

This in-depth analysis examines UFP Technologies, Inc.'s business model, financial performance, competitive positioning, and SWOT analysis as of 2026. Whether you're evaluating UFP Technologies, Inc. as an investment, benchmarking it against peers, or researching its strategy, this guide covers the key factors that define UFP Technologies, Inc.'s position in the Medical Devices market today.

What You Will Learn

1. How UFP Technologies, Inc. generates revenue across its key business segments and the unit economics behind each
2. A data-backed SWOT analysis covering UFP Technologies, Inc.'s competitive strengths, operational weaknesses, market opportunities, and external threats
3. Who UFP Technologies, Inc.'s main competitors are and how the company compares on key financial metrics
4. UFP Technologies, Inc.'s key financial metrics: revenue, profit margins, market cap, free cash flow, and valuation multiples
5. UFP Technologies, Inc.'s strategic direction and what to watch in 2026-2027

Key Takeaways

• Revenue: $602.80 million annual revenue (TTM), +3.4% YoY
• Market Cap: $1.56 billion — one of the largest companies in the Healthcare sector
• Profitability: Gross margin 28.3%, operating margin 14.1%, net margin 11.3%
• Free Cash Flow: $65.67 million
• Return on Equity: 17.8% — strong
• Employees: 4,846 worldwide

Who Owns UFP Technologies, Inc.?

UFP Technologies, Inc. is publicly traded on the NCM under the ticker symbol UFPT. As a public company, it is owned by millions of shareholders ranging from retail investors to major institutional holders.

The largest shareholders of UFP Technologies, Inc. are typically major institutional investors including The Vanguard Group, BlackRock, and State Street Corporation — which collectively often hold 15-25% of publicly traded US companies. Insider ownership and the concentration of voting rights vary; investors should review the latest proxy statement filed with the SEC for precise ownership data.

UFP Technologies, Inc. has approximately 0.01 billion shares outstanding, with float shares of 0.00 billion — the freely tradeable portion. The stock trades at $202.33 per share as of early 2026.

UFP Technologies, Inc.'s Mission Statement

UFP Technologies, Inc.'s strategic mission is aligned with its core business activities in the Medical Devices sector. The company's stated values and mission inform its capital allocation decisions, talent strategy, and long-term product roadmap. Mission statements for public companies are disclosed in annual reports and investor presentations — UFP Technologies, Inc.'s most recent proxy statement and annual report are the authoritative sources for its current mission and values.

A company's mission statement matters because it signals strategic intent to employees, investors, and customers. For UFP Technologies, Inc., the mission encompasses not just what the company does, but why it exists and how it creates value for stakeholders. Companies that maintain alignment between their stated mission and actual capital allocation decisions tend to build stronger brand trust and employee engagement over time.

In practice, UFP Technologies, Inc.'s strategic priorities as communicated to investors in 2025-2026 center on revenue growth and market share expansion, profitability improvement, and sustainable returns of capital to shareholders. These operational priorities translate directly into the business model and investment thesis discussed in the following sections.

How Does UFP Technologies, Inc. Make Money?

As of 2026, UFP Technologies, Inc. generates $602.80 million in annual revenue (growing 3.4% year-over-year), with a 28.3% gross margin and 14.1% operating margin. Market capitalization stands at $1.56 billion. Here is how the company generates its revenue:

How Does UFP Technologies Make Money?

UFP Technologies is a company that specializes in the design and manufacturing of custom-engineered components, products, and packaging primarily for the medical, automotive, aerospace, and industrial markets. Here's a breakdown of the key revenue streams for UFP Technologies:

Custom Engineered Products

One of the primary ways UFP Technologies makes money is through the creation of custom-engineered products. These products are designed to meet the specific needs of their clients across various industries. For instance, in the medical field, UFP Technologies designs and manufactures components for medical devices, surgical equipment, and patient care products. By providing highly specialized solutions, the company adds significant value, allowing them to charge premium prices.

Packaging Solutions

UFP Technologies also generates revenue through its packaging solutions. The company designs and produces custom packaging for a variety of products, ranging from consumer goods to highly sensitive medical devices. These packaging solutions help protect products during shipping and handling, ensuring they arrive in perfect condition. The customized nature of these packaging solutions often allows UFP Technologies to command higher prices compared to standard packaging options.

Aerospace and Defense

In the aerospace and defense sectors, UFP Technologies offers products that meet stringent regulatory and performance standards. The company manufactures components such as thermal insulation, gaskets, and seals that are critical for the performance and safety of aerospace and defense systems. The high level of expertise required in these sectors allows UFP Technologies to charge a premium for their products.

Industrial and Automotive Components

The company also produces a range of components for the industrial and automotive markets. These components are designed to improve the performance, durability, and safety of machinery and vehicles. By offering innovative and high-quality solutions, UFP Technologies can maintain strong relationships with industrial and automotive manufacturers, ensuring a steady stream of revenue.

Research and Development

Another significant aspect of UFP Technologies' business model is its investment in research and development (R&D). By continually innovating and improving their product offerings, the company can stay ahead of competitors and meet the evolving needs of th

In 2026, management's strategic priorities center on operational efficiency, market share expansion, and disciplined capital allocation. Investors should review UFP Technologies, Inc.'s latest annual report and quarterly earnings releases for the most current financial disclosures and strategic updates.

UFP Technologies, Inc. Business Model Canvas

The Business Model Canvas framework provides a structured view of how UFP Technologies, Inc. creates, delivers, and captures value.

Key Partners: UFP Technologies, Inc.'s key partners include suppliers, distributors, technology providers, and strategic alliances that enable its core operations. In the Medical Devices sector, these relationships provide supply chain resilience, expanded distribution, and access to complementary capabilities.

Key Activities: UFP Technologies, Inc.'s most important activities center on product development and innovation, sales and marketing, supply chain management, customer service, and regulatory compliance. The company's ability to execute these activities at scale is a core competency.

Key Resources: UFP Technologies, Inc.'s critical resources include its brand equity, intellectual property portfolio, customer relationships, human capital (4,846 employees), proprietary technology, and financial resources ($20.30M in cash).

Value Propositions: UFP Technologies, Inc. delivers value to customers through product quality, brand trust, convenience, innovation, and price competitiveness. The specific value proposition varies by customer segment but consistently addresses core needs in the Medical Devices market.

Customer Relationships: UFP Technologies, Inc. maintains customer relationships through multiple channels including direct sales teams, digital platforms, customer service centers, and loyalty/membership programs. Customer retention is a key operational priority.

Channels: UFP Technologies, Inc. reaches customers through its own direct channels (stores, website, apps), third-party retailers and distributors, and partner networks. The mix of direct vs. indirect channels affects margin structure and customer data ownership.

Customer Segments: UFP Technologies, Inc. serves multiple distinct customer segments, which may include consumers, small and medium businesses, enterprise clients, and government entities — depending on its product portfolio and market positioning.

Cost Structure: UFP Technologies, Inc.'s major costs include cost of goods sold (71.7% of revenue), research & development, sales & marketing, general & administrative expenses, and capital expenditures. Total operating costs represent 85.9% of revenue.

Revenue Streams: UFP Technologies, Inc. generates revenue through its core product and service offerings.

UFP Technologies, Inc. Competitors

UFP Technologies, Inc. competes against Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Pfizer (PFE), AbbVie (ABBV), Eli Lilly (LLY) and others in the Medical Devices segment of the Healthcare sector.

UFP Technologies, Inc. SWOT Analysis

A SWOT analysis examines UFP Technologies, Inc.'s internal strengths and weaknesses alongside external opportunities and threats.

Strengths

• Solid Profitability: UFP Technologies, Inc. maintains a gross margin of 28.3% and operating margin of 14.1%, demonstrating consistent operational execution and cost discipline in a competitive market.
• Capital Efficiency: A return on equity of 17.8% demonstrates that UFP Technologies, Inc. generates strong returns from shareholder capital, a hallmark of companies with durable competitive advantages.

Weaknesses

• Slowing Growth: Revenue growth of 3.4% is below what growth investors typically seek, suggesting market saturation in core businesses or increasing competitive pressure.

Opportunities

• Total Addressable Market: UFP Technologies, Inc. operates in the Medical Devices segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in this environment translate to meaningful revenue upside, particularly as the company expands its product portfolio and geographic reach.
• International Expansion: Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for UFP Technologies, Inc.'s products and services.
• Strategic Acquisitions: With $20.30M in cash and strong free cash flow generation, UFP Technologies, Inc. is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.

Threats

• Macroeconomic Sensitivity: Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. UFP Technologies, Inc.'s revenue is not fully insulated from macroeconomic cycles, and a recession scenario could meaningfully impact demand.
• Regulatory and Geopolitical Risk: Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on UFP Technologies, Inc.'s business model across key markets.
• Talent Competition: Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly critical in an era of AI-driven competition.

Conclusion

UFP Technologies, Inc. enters 2026 as a leading company in Healthcare, backed by $602.80 million in annual revenue and a 11.3% net profit margin. The company's 28.3% gross margins and $65.67 million in free cash flow provide the financial foundation to fund growth initiatives while returning capital to shareholders.

The primary opportunities ahead lie in expanding market share, operational efficiency improvements, and selective geographic expansion. The key risks to monitor include competitive pressure from established peers and new entrants, macroeconomic headwinds, and regulatory developments in UFP Technologies, Inc.'s core markets.

For investors, UFP Technologies, Inc.'s 23.1x trailing P/E and 17.7x forward P/E reflect the market's expectations for stable earnings. Analysts and investors should watch quarterly earnings releases, management commentary on comparable sales growth, margin trends, and capital allocation for signals of how the investment thesis is progressing.

Data Sources

Financial data and business information for this analysis was sourced from: Yahoo Finance – UFP Technologies, SEC EDGAR – UFP Technologies Filings, and UFP Technologies's investor relations materials.

All financial figures reflect the most recent publicly available disclosures. Investors should verify current data before making investment decisions.

Frequently Asked Questions

1. Strengths

UFP Technologies, Inc.'s core strengths include: UFP Technologies, Inc. maintains a gross margin of 28.3% and operating margin of 14.1%, demonstrating consistent operational execution and cost discipline in a competitive market. A return on equity of 17.8% demonstrates that UFP Technologies, Inc. generates strong returns from shareholder capital, a hallmark of companies with durable competitive advantages. These advantages contribute to the company's durable competitive position in the Medical Devices sector.

2. Weaknesses

UFP Technologies, Inc.'s primary weaknesses include: Revenue growth of 3.4% is below what growth investors typically seek, suggesting market saturation in core businesses or increasing competitive pressure. These factors represent risks that investors and analysts should weigh against the company's competitive strengths.

3. Opportunities

UFP Technologies, Inc.'s key growth opportunities include: UFP Technologies, Inc. operates in the Medical Devices segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in this envir Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for UFP Tec With $20.30M in cash and strong free cash flow generation, UFP Technologies, Inc. is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.

4. Threats

UFP Technologies, Inc. faces the following external threats: Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. UFP Technologies, Inc.'s revenue is not fully insulated from macroeconomic cycles, and a rec Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on UFP Technologies, I Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly cri Monitoring these risks is essential for investors tracking the company's long-term trajectory.

5. Who are the competitors of UFP Technologies?

UFP Technologies, Inc. competes in the Medical Devices segment of the Healthcare sector. The competitor comparison table in this article outlines key peers by market cap, revenue, and margins. Competitive dynamics in Medical Devices center on product differentiation, pricing strategy, and distribution scale.

6. What is the mission statement of UFP Technologies?

UFP Technologies, Inc.'s mission and core values are disclosed in its annual report and investor relations materials. The company's stated strategic priorities — as communicated in 2025-2026 earnings calls — center on sustainable growth, operational efficiency, and shareholder returns.

7. What do UFP Technologies do?

UFP Technologies, Inc. generated $602.80 million in annual revenue with a 11.3% net profit margin as of the latest reporting period. The company operates in the Medical Devices sector. For the most current information, consult UFP Technologies, Inc.'s investor relations page.